Capital Advisors Ltd. adds DaVita HealthCare Partners Inc (DVA) to its portfolio

DaVita HealthCare Partners Inc (DVA) : Capital Advisors Ltd. added new position in DaVita HealthCare Partners Inc during the most recent quarter end. The investment management firm now holds 500 shares of DaVita HealthCare Partners Inc which is valued at $31,425 , the company said in a statement filed on Oct 14, 2016 with the SEC.DaVita HealthCare Partners Inc makes up approximately 0.01% of Capital Advisors Ltd.’s portfolio.

Other Hedge Funds, Including , Atria Investments reduced its stake in DVA by selling 673 shares or 14.75% in the most recent quarter. The Hedge Fund company now holds 3,890 shares of DVA which is valued at $241,180. DaVita HealthCare Partners Inc makes up approx 0.02% of Atria Investments’s portfolio.Carroll Financial Associates reduced its stake in DVA by selling 219 shares or 71.1% in the most recent quarter. The Hedge Fund company now holds 89 shares of DVA which is valued at $5,669.Exxonmobil Investment Management Inc Tx boosted its stake in DVA in the latest quarter, The investment management firm added 35 additional shares and now holds a total of 42,263 shares of DaVita HealthCare Partners Inc which is valued at $2,680,742. DaVita HealthCare Partners Inc makes up approx 0.06% of Exxonmobil Investment Management Inc Tx’s portfolio. Simplex Trading sold out all of its stake in DVA during the most recent quarter. The investment firm sold 817 shares of DVA which is valued $51,822.

DaVita HealthCare Partners Inc closed down -0.14 points or -0.22% at $62.85 with 13,29,729 shares getting traded on Friday. Post opening the session at $63.02, the shares hit an intraday low of $62.84 and an intraday high of $63.34 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, DaVita HealthCare Partners Inc reported $1.01 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.98. The company had revenue of $3718.00 million for the quarter, compared to analysts expectations of $3658.91 million. The company’s revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.95 EPS.

Many Wall Street Analysts have commented on DaVita HealthCare Partners Inc. DaVita HealthCare Partners Inc was Upgraded by Raymond James to ” Outperform” on Sep 20, 2016. DaVita HealthCare Partners Inc was Downgraded by BofA/Merrill to ” Neutral” on Sep 6, 2016. DaVita HealthCare Partners Inc was Initiated by Citigroup to “Neutral” on Sep 6, 2016.

DaVita HealthCare Partners Inc. consists of two divisions Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care offers integrated treatment plans personalized care teams and health-management services. As of December 31 2014 we provided dialysis and administrative services in the U.S. through a network of 2179 outpatient dialysis centers in 46 states and the District of Columbia serving a total of approximately 173000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona California Nevada Florida and New Mexico. As of December 2014 HealthCare Partners had approximately 837000 members under its care.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

DaVita HealthCare Partners Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on DaVita HealthCare Partners Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.